Jonathan R. McGrath
Chief Executive Officer at Neograft Technologies, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Albert Bourla | M | 62 | 31 years | |
| Rady Johnson | M | 63 | 30 years | |
| Richard C. Petersen | M | - |
Neograft Technologies, Inc.
 Neograft Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Neograft Technologies, Inc. engages in the research and development in tissue engineering and regenerative medicine. Its product Angioshield, addresses inherent limits associated with using veins for coronary bypass surgery. The company was founded by Mohammed El-Kurdi in 2009 and is headquartered in Taunton, MA. | - |
| Richard J. Faleschini | M | 77 |
BioSphere Medical, Inc.
 BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | 20 years |
| John H. MacKinnon | M | 83 |
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | 21 years |
| Peter Chandler Sutcliffe | M | 74 |
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | 22 years |
| Michael Tovian | M | - |
Neograft Technologies, Inc.
Neograft Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Neograft Technologies, Inc. engages in the research and development in tissue engineering and regenerative medicine. Its product Angioshield, addresses inherent limits associated with using veins for coronary bypass surgery. The company was founded by Mohammed El-Kurdi in 2009 and is headquartered in Taunton, MA. | - |
| Thomas M. Dugan | M | - |
Neograft Technologies, Inc.
Neograft Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Neograft Technologies, Inc. engages in the research and development in tissue engineering and regenerative medicine. Its product Angioshield, addresses inherent limits associated with using veins for coronary bypass surgery. The company was founded by Mohammed El-Kurdi in 2009 and is headquartered in Taunton, MA. | - |
| Christopher S. Petersen | M | - |
Neograft Technologies, Inc.
Neograft Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Neograft Technologies, Inc. engages in the research and development in tissue engineering and regenerative medicine. Its product Angioshield, addresses inherent limits associated with using veins for coronary bypass surgery. The company was founded by Mohammed El-Kurdi in 2009 and is headquartered in Taunton, MA. | - |
| Brad Richard Petersen | M | - |
Neograft Technologies, Inc.
Neograft Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Neograft Technologies, Inc. engages in the research and development in tissue engineering and regenerative medicine. Its product Angioshield, addresses inherent limits associated with using veins for coronary bypass surgery. The company was founded by Mohammed El-Kurdi in 2009 and is headquartered in Taunton, MA. | - |
| John DeYoung | M | 61 | 33 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Constance J. Horner | F | 82 | - | |
| Wesley Johnson | M | 65 | 4 years | |
| Jack Edward Meyer | M | 80 | 4 years | |
| Martin MacKay | M | 68 | 14 years | |
| Jacob M. Plotsker | M | 56 | 16 years | |
| James R. Thomas | M | 73 | 19 years | |
| Roy Tanaka | M | 75 | 3 years | |
| James J. Dolan | M | - | - | |
| Jay T. Goodwin | M | - | - | |
| Patrick W. Fabian | M | 56 | 3 years | |
| Michael T. Sweeney | M | 63 | 8 years | |
| Suhail Nurbhai | M | - | 12 years | |
| Marylou Walker | F | 58 | 10 years | |
| Samuel Yonren | M | - | - | |
| Andrew B. McCormick | M | - | - | |
| George E. Stagnitti | M | - | 5 years | |
| Brian Pollok | M | - | 4 years | |
| Jay Olson | M | - | 16 years | |
| James Kuo | M | 58 | 2 years | |
| Thomas G. Gant | M | - | 6 years | |
| Beth Levine | F | 60 | 13 years | |
| Peter Hamilton | M | - |
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | 7 years |
| Dan G. Keller | M | 65 | - | |
| Pedro Lichtinger | M | 70 | 14 years | |
| Donald G. Anderson | M | - |
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | 2 years |
| Hugh M. Donnelly | M | - | - | |
| Michael Dunne | M | 64 | 17 years | |
| Sef P. Kurstjens | M | 60 | 12 years | |
| Uma Kuruganti | F | - | 20 years | |
| Robert Clark | M | 64 | 29 years | |
| Ravi Kiron | M | 64 | 13 years | |
| Robert Sheroff | M | 69 | 7 years | |
| Timothy Rolph | M | 70 | 22 years | |
| Natasha Kehimkar | F | - | 16 years | |
| Mary R. Flack | M | - | 7 years | |
| James New | M | 70 | 5 years | |
| Michael Mydra | M | - | 5 years | |
| Ken Keyong Ren | M | 64 | 2 years | |
| Howard Donnelly | M | 63 | 9 years | |
| Karen Dawes | F | 72 | 10 years | |
| Mary Winston | F | 62 | 7 years | |
| Martin Joyce | M | 70 |
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | 6 years |
| David L. Brinkley | M | 66 | - | |
| Gary M. Saxton | M | 63 |
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | 3 years |
| Douglas A. Hamilton | M | 57 | 4 years | |
| Bruce S. Lamb | M | 68 | 6 years | |
| Richard Bagger | M | 63 | 17 years | |
| Douglas Giordano | M | 61 | 30 years | |
| Jon Coleman | M | 60 | 12 years | |
| Patricia Andrews | F | 66 | 17 years | |
| Michael Megna | M | 53 |
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | 6 years |
| Franklin Raines | M | 74 | 3 years | |
| John Overington | M | - | - | |
| Charles A. Baker | M | 91 | 19 years | |
| Henrik Rasmussen | M | 65 | 5 years | |
| Wendell Wierenga | M | 76 | 10 years | |
| Walter Moos | M | 69 | 9 years | |
| Patricia A. Beithon | F | 69 | 9 years | |
| Kevin Koch | M | 63 | 7 years | |
| William R. Shanahan | M | 74 | 4 years | |
| Robert Zerbe | M | 73 | 7 years | |
| Scott Kay | M | - | 7 years | |
| Feargal Mooney | M | 54 | 3 years | |
| Wesley W. Day | M | 59 | 12 years | |
| Robert Rebak | M | 57 | 2 years | |
| Robert Cohen | M | 66 | 11 years | |
| Joshua Makower | M | 60 | - | |
| Michael Hodges | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 79 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jonathan R. McGrath
- Personal Network
